AR127456A1 - Sintesis de [1,2,3]triazol[4,5-d]pirimidinas - Google Patents

Sintesis de [1,2,3]triazol[4,5-d]pirimidinas

Info

Publication number
AR127456A1
AR127456A1 ARP220102901A ARP220102901A AR127456A1 AR 127456 A1 AR127456 A1 AR 127456A1 AR P220102901 A ARP220102901 A AR P220102901A AR P220102901 A ARP220102901 A AR P220102901A AR 127456 A1 AR127456 A1 AR 127456A1
Authority
AR
Argentina
Prior art keywords
alkyl
phenyl
halo
alkoxy
compound
Prior art date
Application number
ARP220102901A
Other languages
English (en)
Inventor
Jean Adam
- Grether Uwe Michel
Christian Moessner
Paolo Tosatti
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR127456A1 publication Critical patent/AR127456A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

La presente invención se refiere a un proceso para la preparación de derivados de [1,2,3]triazolo[4,5-d]pirimidina útiles como compuestos farmacéuticamente activos, en particular, 1-[5-ter-butil-3-[(1-metiltetrazol-5-il)metil]triazolo[4,5-d]pirimidin-7-il]pirrolidin-3-ol. Reivindicación 1: Un proceso para la preparación del compuesto de fórmula (1) o una sal farmacéuticamente aceptable, en donde R¹ es halógeno, -OH, -NRᵃRᵇ, alcoxi (C₁-C₆), alquil (C₁-C₆), -O(O)CRᶜ o -NRᵃC(O)Rᶜ; Rᵃ y Rᵇ se eligen independientemente de H, alquilo (C₁-C₆), alcoxi (C₁-C₆), halo-alquil (C₁-C₆), fenilo, halo-fenilo o alquil (C₁-C₆)-fenilo; Rᶜ se elige independientemente de H, alquil (C₁-C₆), alcoxi (C₁-C₆), -OH, halo-alquil (C₁-C₆), fenilo, halo-fenilo o alquil (C₁-C₆)-fenilo; que comprende hacer reaccionar un compuesto de fórmula (2), sales de este, un tautómero de este o una mezcla de tautómeros de este con un compuesto de fórmula (3) en donde X es halógeno, triflato o tosilo; en presencia de un ácido orgánico.
ARP220102901A 2021-10-28 2022-10-26 Sintesis de [1,2,3]triazol[4,5-d]pirimidinas AR127456A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21205140 2021-10-28
EP22155794 2022-02-09

Publications (1)

Publication Number Publication Date
AR127456A1 true AR127456A1 (es) 2024-01-24

Family

ID=84361902

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102901A AR127456A1 (es) 2021-10-28 2022-10-26 Sintesis de [1,2,3]triazol[4,5-d]pirimidinas

Country Status (3)

Country Link
AR (1) AR127456A1 (es)
TW (1) TW202334152A (es)
WO (1) WO2023072978A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA111640C2 (uk) 2011-11-08 2016-05-25 Ф. Хоффманн-Ля Рош Аг ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
US9067943B2 (en) * 2011-11-25 2015-06-30 Hoffmann-La Roche Inc. [1,2,3]triazolo[4,5-D]pyrimidine derivatives

Also Published As

Publication number Publication date
TW202334152A (zh) 2023-09-01
WO2023072978A1 (en) 2023-05-04

Similar Documents

Publication Publication Date Title
ES2285239T3 (es) Derivados de heteroarilnitrilo.
ES2208578T3 (es) Derivados n-heterociclicos utilizados como inhibidores de la oxido nitrico sintasa.
US3211731A (en) Pyrazolo-pyrimidines and process for preparing same
US10464927B2 (en) 2,4-disubstituted pyrimidines as CDK inhibitors
AU2014400628B2 (en) Aminopyridazinone compounds as protein kinase inhibitors
BRPI0208811B1 (pt) Derivados de pirazol, seu uso e processo de preparação, bem como composição farmacêutica compreendendo os mesmos
US20080261988A1 (en) IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
WO2002088084A1 (fr) Derives de composes heterocycliques et medicaments
KR20150126051A (ko) Dna-pk 억제제
El-Gaby et al. Studies on aminopyrazoles: antibacterial activity of some novel pyrazolo [1, 5-a] pyrimidines containing sulfonamido moieties
BG65453B1 (bg) Азотсъдържащи ароматни 6-членни циклични съединения, фармацевтични състави на тяхна база и използването им като лекарствени средства
KR20050085115A (ko) 신규 화합물
HU219405B (hu) Eljárás aril- (vagy heteroaril)-piperazinil-butil-azol-származékok előállítására
HRP980222A2 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
US9156847B2 (en) Processes and intermediates for preparing a medicament
CA2040235A1 (en) Benzimidazolinone derivatives
US20200181149A1 (en) Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
EP3863635A1 (en) Thyroid hormone receptor beta agonist compounds
Landreau et al. Efficient regioselective synthesis of triheterocyclic compounds: imidazo [2, 1-b] benzothiazoles, pyrimido [2, 1-b] benzothiazolones and pyrimido [2, 1-b] benzothiazoles
AR127456A1 (es) Sintesis de [1,2,3]triazol[4,5-d]pirimidinas
EP0177287A2 (en) Pyrimidine derivatives, processes for preparation thereof and composition of the same
US4666915A (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same
US4303789A (en) 2-Amino-4-(substituted hydrazino)-6-imino pyrimidines
JP2004517930A (ja) サイクリン依存性キナーゼ阻害プリン誘導体類
CZ307217B6 (cs) Zlepšený způsob výroby a nové intermediáty syntézy ticagreloru